Compare the Safety and Efficacy of Genoss® DCB and SeQuent® Please NEO in Korean Patients With Coronary De Novo Lesions
Clinical trial NCT05096442 · COMPLETED
Trial details
- NCT number
- NCT05096442
- Sponsor
- Genoss Co., Ltd.
- Status
- COMPLETED
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2021-09-30
- Primary completion
- 2023-06-28
- Enrollment
- 204
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.